Nuzenio

Tipranks Arrowhead

Tipranks Arrowhead news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Arrowhead price target raised to $120 from $115 at H.C. Wainwright - TipRanksTipRanks · Thu, 06 Aug 2026 17:48:37 GMTAnalysts Are Bullish on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Beam Therapeutics (BEAM) - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 18:10:00 GMTArrowhead: Buy Rating Reiterated as Redemplo Momentum Builds and Pipeline Catalysts Support Unchanged $120 Price Target - TipRanksTipRanks · Wed, 05 Aug 2026 15:37:00 GMTPiper Sandler Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP) - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 13:38:00 GMTArrowhead: Strong Phase III Plozasiran Data and Priority Review Voucher Drive Accelerated Path to Market and $3B Global Sales Outlook, Supporting Buy Rating - TipRanksTipRanks · Wed, 05 Aug 2026 09:36:55 GMTArrowhead reports Q3 EPS ($1.36), consensus ($1.23) - TipRanksTipRanks · Wed, 05 Aug 2026 00:13:53 GMTArrowhead acquires FDA priority review voucher - TipRanksTipRanks · Tue, 04 Aug 2026 23:01:03 GMT

Timeline

Thu, 06 Aug 2026 17:48:37 GMTArrowhead price target raised to $120 from $115 at H.C. Wainwright - TipRanks
Wed, 05 Aug 2026 18:10:00 GMTAnalysts Are Bullish on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Beam Therapeutics (BEAM) - The Globe and Mail
Wed, 05 Aug 2026 15:37:00 GMTArrowhead: Buy Rating Reiterated as Redemplo Momentum Builds and Pipeline Catalysts Support Unchanged $120 Price Target - TipRanks
Wed, 05 Aug 2026 13:38:00 GMTPiper Sandler Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP) - The Globe and Mail
Wed, 05 Aug 2026 09:36:55 GMTArrowhead: Strong Phase III Plozasiran Data and Priority Review Voucher Drive Accelerated Path to Market and $3B Global Sales Outlook, Supporting Buy Rating - TipRanks
Wed, 05 Aug 2026 00:13:53 GMTArrowhead reports Q3 EPS ($1.36), consensus ($1.23) - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tipranks Arrowhead.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.